| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/01/2005 | US20050266493 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
| 12/01/2005 | US20050266492 By multi-locus variable number tandem repeats (VNTR) analysis (MLVA) genotyping system of VNTR identified within the genome; solid phase synthesis; kits; tuberculosum genotyping |
| 12/01/2005 | US20050266490 Using membrane protein as tool in identifying modulators for prevention and treatment of cell proliferative, autoimmune, inflammatory, nervous system and metabolic disorders |
| 12/01/2005 | US20050266489 Processing and amplifying target nucleic acid sequence present in a fluid sample via processive reaction in open-mouthed vessel containing solid support; genomic analysis and gene diagnostics |
| 12/01/2005 | US20050266488 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna |
| 12/01/2005 | US20050266487 High fidelity thermostable ligase and uses thereof |
| 12/01/2005 | US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant |
| 12/01/2005 | US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer |
| 12/01/2005 | US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria |
| 12/01/2005 | US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/01/2005 | US20050266482 Regulation of human CYSLT2-like GPCR protein |
| 12/01/2005 | US20050266481 primer is used as surrogate markers in diagnostic assays for Hereditary hemochromatosis, genetic disorders |
| 12/01/2005 | US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia |
| 12/01/2005 | US20050266478 Biochips including ion transport detecting structures and methods of use |
| 12/01/2005 | US20050266477 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 12/01/2005 | US20050266476 Dual bead assays including covalent linkages for improved specificity and related optical analysis discs |
| 12/01/2005 | US20050266474 Common marmoset-derived glyceraldehyde-3-phosphate dehydrogenase gene and use thereof |
| 12/01/2005 | US20050266473 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
| 12/01/2005 | US20050266472 Apparatus and method for detecting bio molecule using inductance device |
| 12/01/2005 | US20050266471 Common marmoset-derived beta-actin gene and use thereof |
| 12/01/2005 | US20050266470 25501, a human transferase family member and uses therefor |
| 12/01/2005 | US20050266469 Alternatively spliced isoforms of checkpoint kinase 1 (CHK1) |
| 12/01/2005 | US20050266468 real time polymerase chain reactions |
| 12/01/2005 | US20050266467 Biomarkers for multiple sclerosis and methods of use thereof |
| 12/01/2005 | US20050266466 Microarray-based method for amplifying and detecting nucleic acids during a continuous process |
| 12/01/2005 | US20050266465 Interferon-alpha polypeptides and conjugates |
| 12/01/2005 | US20050266464 C1q family member proteins with altered immunogenicity |
| 12/01/2005 | US20050266462 Magnetic glass particles, method for their preparation and uses thereof |
| 12/01/2005 | US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/01/2005 | US20050266460 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 12/01/2005 | US20050266459 Nucleic acid probes and nucleic acid analog probes |
| 12/01/2005 | US20050266458 methylation of specific target nucleotides (cytosine residues) in target nucleic acid sequences, typically genomic DNA (gDNA); DNA methylation markers as diagnostic indicators; detection of (mis)ligation products e.g., digested, amplified, reporter probes |
| 12/01/2005 | US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 12/01/2005 | US20050266456 Field-switch sequencing |
| 12/01/2005 | US20050266455 Method and microelectronic device for multi-site molecule detection |
| 12/01/2005 | US20050266454 Polypeptide comprising myosin kinase activity for as use tool in identifying modulators for treatment of metabolic disorders |
| 12/01/2005 | US20050266452 Novel human kinases and polynucleotides encoding the same |
| 12/01/2005 | US20050266451 Obtaining antibodies with desired characteristics by isolating complementary determining regions DNA sequences and incorporating them into scaffold; shuffling polynucleotide sequences |
| 12/01/2005 | US20050266450 Method for analyzing a target nucleic acid fragment and a kit for analyzing a target nucleic acid fragment |
| 12/01/2005 | US20050266449 Method of detecting a hybrid, formed of at least two species, on a substrate |
| 12/01/2005 | US20050266448 Method of nucleic acid analysis, nucleic acid analysis device and disk for nucleic acid analysis |
| 12/01/2005 | US20050266447 Method for identifying activators of gene transcription |
| 12/01/2005 | US20050266446 Human ITPase-related gene variants associated with lung cancers |
| 12/01/2005 | US20050266445 Purified mammalian CTLA-8 antigens and related reagents |
| 12/01/2005 | US20050266444 Generating genomic patterning array for preferential cellular tissues; gene and genome mapping |
| 12/01/2005 | US20050266443 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 12/01/2005 | US20050266442 Immortalized human Tuberous Sclerosis null angiomyolipoma cell and method of use thereof |
| 12/01/2005 | US20050266441 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| 12/01/2005 | US20050266440 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants |
| 12/01/2005 | US20050266439 Thermostable RNA ligase from thermus phage |
| 12/01/2005 | US20050266438 Genetic networks regulated by attenuated GH/IGF1 signaling and caloric restriction |
| 12/01/2005 | US20050266437 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 12/01/2005 | US20050266436 thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3'-5'-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR. |
| 12/01/2005 | US20050266435 VR1 receptors and uses thereof |
| 12/01/2005 | US20050266434 Biosynthetic gene cluster for ambruticins |
| 12/01/2005 | US20050266433 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 12/01/2005 | US20050266432 Haplotype markers for diagnosing susceptibility to immunological conditions |
| 12/01/2005 | US20050266430 A mutated G-CSF mRNA or cDNA fragment having a deletion of an exon 3 region for use; primer for use in amplification of a G-CSF gene |
| 12/01/2005 | US20050266429 Magnetic pigment |
| 12/01/2005 | US20050266427 Biomolecule/polymer conjugates |
| 12/01/2005 | US20050266426 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 12/01/2005 | US20050266425 Methods for producing and identifying multispecific antibodies |
| 12/01/2005 | US20050266424 Real-time sequence determination |
| 12/01/2005 | US20050266423 Novel nucleic acids and polypeptides |
| 12/01/2005 | US20050266422 Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides |
| 12/01/2005 | US20050266421 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 12/01/2005 | US20050266420 Multigene predictors of response to chemotherapy |
| 12/01/2005 | US20050266419 Sample is split into parts and the parts are flowed through chromatography columns containing nucleic acid oligomer probes bound to a binding medium; analyte oligomers are transiently hybridized to complementary probe oligomers during chromatography; detection and analysis of oligomer peaks |
| 12/01/2005 | US20050266418 MicroRNA; peptide nucleic acids; locked nucleic acids |
| 12/01/2005 | US20050266417 Methods for identifying target nucleic acid molecules |
| 12/01/2005 | US20050266416 Molecular nanomotor |
| 12/01/2005 | US20050266415 Method for sampling gas-borne matter |
| 12/01/2005 | US20050266414 Carrier tests for albinism in the cat |
| 12/01/2005 | US20050266412 Method of amplifying infectious protein |
| 12/01/2005 | US20050266411 Methods for rapid forensic analysis of mitochondrial DNA |
| 12/01/2005 | US20050266410 Methods of Human Leukocyte Antigen typing by neighboring single nucleotide polymorphism haplotypes |
| 12/01/2005 | US20050266409 Compositions and methods for diagnosing, preventing, and treating cancers |
| 12/01/2005 | US20050266408 used in linkage analysis to track disease genes in human pedigrees or economically important traits in animal and plant breeding programmes; forensic and paternity testing; to discover mutations in biologically and clinically important genes |
| 12/01/2005 | US20050266407 Using probes having priming sequence complementary to primer sequence, variable sequence and nucleotide; decoding microsphere array senors |
| 12/01/2005 | US20050266406 Maxs as modifiers of the axin pathway and methods of use |
| 12/01/2005 | US20050266405 Analysis of apoptotic bodies in bodily fluids |
| 12/01/2005 | US20050266404 Detection method of nucleic acid hybridization |
| 12/01/2005 | US20050266403 Method for analyzing base sequence of nucleic acid |
| 12/01/2005 | US20050266402 Compositions and methods for binding agglomeration proteins |
| 12/01/2005 | US20050266401 Compositions and methods for binding agglomeration proteins |
| 12/01/2005 | US20050266400 Novel sequences encoding hepatitis C virus glycoproteins |
| 12/01/2005 | US20050266399 HCV regulated protein expression |
| 12/01/2005 | US20050266398 Method and device for rapid detection and quantitation of macro and micro matrices |
| 12/01/2005 | US20050266397 Methods for identification of coronaviruses |
| 12/01/2005 | US20050266396 Dielectric relaxation spectroscopy apparatus and methods of use |
| 12/01/2005 | US20050266395 Method and system for morphology based mitosis identification and classification of digital images |
| 12/01/2005 | US20050266394 Magnetophoretic cell clarification |
| 12/01/2005 | US20050266393 Circulating flow device for assays of cell cultures, cellular components and cell products |
| 12/01/2005 | US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance |
| 12/01/2005 | US20050265987 Sulfatases and methods of use thereof |
| 12/01/2005 | US20050265975 Method for selective inactivation of viral replication |
| 12/01/2005 | US20050265924 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 12/01/2005 | US20050265922 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 12/01/2005 | US20050265921 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 12/01/2005 | US20050265897 Biosensor and method for manufacturing same |